BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sheikh A, Md S, Kesharwani P. RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy. J Control Release 2021;340:221-42. [PMID: 34757195 DOI: 10.1016/j.jconrel.2021.10.028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang G, Jiang Y, Xu J, Shen J, Lin T, Chen J, Fei W, Qin Y, Zhou Z, Shen Y, Huang P. Unraveling the Plasma Protein Corona by Ultrasonic Cavitation Augments Active-Transporting of Liposome in Solid Tumor. Adv Mater 2023;35:e2207271. [PMID: 36479742 DOI: 10.1002/adma.202207271] [Reference Citation Analysis]
2 Jagdale S, Narwade M, Sheikh A, Md S, Salve R, Gajbhiye V, Kesharwani P, Gajbhiye KR. GLUT1 transporter-facilitated solid lipid nanoparticles loaded with anti-cancer therapeutics for ovarian cancer targeting. International Journal of Pharmaceutics 2023. [DOI: 10.1016/j.ijpharm.2023.122894] [Reference Citation Analysis]
3 Zhao N, Sun Q, Zhang L, Jin H, Zhang M, Liu S, Xin H. Fe(3)O(4) Composite Superparticles with RGD/Magnetic Dual-Targeting Capabilities for the Imaging and Treatment of Non-Small Cell Lung Cancer. ACS Omega 2023;8:7891-903. [PMID: 36873026 DOI: 10.1021/acsomega.2c07647] [Reference Citation Analysis]
4 Zhu J, Li X, Gao W, Jing J. Integrin Targeting Enhances the Antimelanoma Effect of Annexin V in Mice. Int J Mol Sci 2023;24. [PMID: 36835282 DOI: 10.3390/ijms24043859] [Reference Citation Analysis]
5 Aziz A, Rehman U, Sheikh A, Abourehab MAS, Kesharwani P. Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy. J Biomater Sci Polym Ed 2023;34:398-418. [PMID: 36083788 DOI: 10.1080/09205063.2022.2121592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Fu X, Rehman U, Wei L, Chen ZS, Abourehab MAS, Kesharwani P, Cheng ZH. Silver-dendrimer nanocomposite as emerging therapeutics in anti-bacteria and beyond. Drug Resist Updat 2023;68:100935. [PMID: 36774747 DOI: 10.1016/j.drup.2023.100935] [Reference Citation Analysis]
7 Zhang M, Xu H. Peptide-assembled nanoparticles targeting tumor cells and tumor microenvironment for cancer therapy. Front Chem 2023;11:1115495. [PMID: 36762192 DOI: 10.3389/fchem.2023.1115495] [Reference Citation Analysis]
8 Zeng L, Gowda BHJ, Ahmed MG, Abourehab MAS, Chen ZS, Zhang C, Li J, Kesharwani P. Advancements in nanoparticle-based treatment approaches for skin cancer therapy. Mol Cancer 2023;22:10. [PMID: 36635761 DOI: 10.1186/s12943-022-01708-4] [Reference Citation Analysis]
9 Liu Z, Parveen N, Rehman U, Aziz A, Sheikh A, Abourehab MAS, Guo W, Huang J, Wang Z, Kesharwani P. Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer. Mol Cancer 2023;22:8. [PMID: 36635659 DOI: 10.1186/s12943-022-01696-5] [Reference Citation Analysis]
10 Sheikh A, Kaur H, Abourehab MA, Alam MS, Kesharwani P. Aptamer-functionalized dendrimers for targeted cancer therapy. Aptamers Engineered Nanocarriers for Cancer Therapy 2023. [DOI: 10.1016/b978-0-323-85881-6.00027-0] [Reference Citation Analysis]
11 Rout SR, Kenguva G, Sharma D, Sahebkar A, Aeri V, Kesharwani P, Dandela R. Gene therapy using PLGA nanoparticles. Poly(Lactic-Co-glycolic Acid) (PLGA) Nanoparticles for Drug Delivery 2023. [DOI: 10.1016/b978-0-323-91215-0.00009-1] [Reference Citation Analysis]
12 Giri L, Kenguva G, Rout SR, Abourehab MA, Kesharwani P, Dandela R. Dispersions of carbon nanotubes and its biomedical and diagnostic applications. Emerging Applications of Carbon Nanotubes in Drug and Gene Delivery 2023. [DOI: 10.1016/b978-0-323-85199-2.00007-8] [Reference Citation Analysis]
13 Dey A, Kesharwani P, Dubey SK. Actively targeted nanoparticles in photodynamic therapy. Nanomaterials for Photodynamic Therapy 2023. [DOI: 10.1016/b978-0-323-85595-2.00014-1] [Reference Citation Analysis]
14 Kesharwani P, Sheikh A, Abourehab MA, Salve R, Gajbhiye V. A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for triple negative breast cancer therapy. Journal of Drug Delivery Science and Technology 2023. [DOI: 10.1016/j.jddst.2023.104164] [Reference Citation Analysis]
15 Kesharwani P, Chadar R, Shukla R, Jain GK, Aggarwal G, Abourehab MAS, Sahebkar A. Recent advances in multifunctional dendrimer-based nanoprobes for breast cancer theranostics. J Biomater Sci Polym Ed 2022;33:2433-71. [PMID: 35848467 DOI: 10.1080/09205063.2022.2103627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
16 Musyuni P, Bai J, Sheikh A, Vasanthan KS, Jain GK, Abourehab MA, Lather V, Aggarwal G, Kesharwani P, Pandita D. Precision Medicine: Ray of Hope in Overcoming Cancer Multidrug Resistance. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100889] [Reference Citation Analysis]
17 Guo H, Wang L, Wu W, Guo M, Yang L, Zhang Z, Cao L, Pu F, Huang X, Shao Z. Engineered biomimetic nanoreactor for synergistic photodynamic-chemotherapy against hypoxic tumor. J Control Release 2022;351:151-63. [PMID: 36122895 DOI: 10.1016/j.jconrel.2022.09.020] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Arora V, Abourehab MA, Modi G, Kesharwani P. Dendrimers as prospective nanocarrier for targeted delivery against lung cancer. European Polymer Journal 2022;180:111635. [DOI: 10.1016/j.eurpolymj.2022.111635] [Reference Citation Analysis]
19 Li H, Zha S, Li H, Liu H, Wong KL, All AH. Polymeric Dendrimers as Nanocarrier Vectors for Neurotheranostics. Small 2022;18:e2203629. [PMID: 36084240 DOI: 10.1002/smll.202203629] [Reference Citation Analysis]
20 Fatima M, Abourehab MAS, Aggarwal G, Jain GK, Sahebkar A, Kesharwani P. Advancement of cell-penetrating peptides in combating triple-negative breast cancer. Drug Discov Today 2022;27:103353. [PMID: 36099963 DOI: 10.1016/j.drudis.2022.103353] [Reference Citation Analysis]
21 Singh V, Eljaaly K, Md S, Alhakamy NA, Kesharwani P. Triblock copolymeric drug delivery as an emerging nanocarrier for treatment of infectious diseases. Journal of Drug Delivery Science and Technology 2022;75:103691. [DOI: 10.1016/j.jddst.2022.103691] [Reference Citation Analysis]
22 Mukherjee S, Mukherjee S, Abourehab MA, Sahebkar A, Kesharwani P. Exploring dendrimer-based drug delivery systems and their potential applications in cancer immunotherapy. European Polymer Journal 2022;177:111471. [DOI: 10.1016/j.eurpolymj.2022.111471] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
23 Gupta P, Sheikh A, Abourehab MAS, Kesharwani P. Amelioration of Full-Thickness Wound Using Hesperidin Loaded Dendrimer-Based Hydrogel Bandages. Biosensors 2022;12:462. [DOI: 10.3390/bios12070462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Singh N, Handa M, Singh V, Kesharwani P, Shukla R. Lymphatic targeting for therapeutic application using nanoparticulate systems. J Drug Target 2022;:1-34. [PMID: 35722764 DOI: 10.1080/1061186X.2022.2092741] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Tambe V, Patel S, Shard A, Behera SK, Polaka S, Anup N, Gadeval A, Kalia K, Tekade RK. Dendronized Polymeric Biomaterial for Loading, Stabilization, and Targeted Cytosolic Delivery of microRNA in Cancer Cells. ACS Appl Bio Mater . [DOI: 10.1021/acsabm.2c00179] [Reference Citation Analysis]
26 Dubey SK, Dey A, Singhvi G, Pandey MM, Singh V, Kesharwani P. Emerging trends of nanotechnology in advanced cosmetics. Colloids Surf B Biointerfaces 2022;214:112440. [PMID: 35344873 DOI: 10.1016/j.colsurfb.2022.112440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
27 Fatima M, Sheikh A, Hasan N, Sahebkar A, Riadi Y, Kesharwani P. Folic acid conjugated poly(amidoamine) dendrimer as a smart nanocarriers for tracing, imaging, and treating cancers over-expressing folate receptors. European Polymer Journal 2022;170:111156. [DOI: 10.1016/j.eurpolymj.2022.111156] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
28 Kumar Dubey S, Dabholkar N, Narayan Pal U, Singhvi G, Kumar Sharma N, Puri A, Kesharwani P. Emerging innovations in cold plasma therapy against cancer: a paradigm shift. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.05.014] [Reference Citation Analysis]
29 Bapat RA, Yang HJ, Chaubal TV, Dharmadhikari S, Abdulla AM, Arora S, Rawal S, Kesharwani P. Review on synthesis, properties and multifarious therapeutic applications of nanostructured zirconia in dentistry. RSC Adv 2022;12:12773-93. [PMID: 35496329 DOI: 10.1039/d2ra00006g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Singh A, Ujjwal RR, Naqvi S, Verma RK, Tiwari S, Kesharwani P, Shukla R. Formulation development of tocopherol polyethylene glycol nanoengineered polyamidoamine dendrimer for neuroprotection and treatment of alzheimer disease. J Drug Target 2022;:1-52. [PMID: 35382657 DOI: 10.1080/1061186X.2022.2063297] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
31 Sheikh A, Md S, Alhakamy NA, Kesharwani P. Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121751] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
32 Singh S, Aldawsari HM, Alam A, Alqarni MHS, Ranjan S, Kesharwani P. Synthesis and antimicrobial activity of vancomycin–conjugated zinc coordination polymer nanoparticles against methicillin-resistant staphylococcus aureus. Journal of Drug Delivery Science and Technology 2022;70:103255. [DOI: 10.1016/j.jddst.2022.103255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Akter S, Rahman MA, Hasan MN, Akhter H, Noor P, Islam R, Shin Y, Rahman MH, Gazi MS, Huda MN, Nam NM, Chung J, Han S, Kim B, Kang I, Ha J, Choe W, Choi TG, Kim SS. Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements. Cells 2022;11:650. [DOI: 10.3390/cells11040650] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 20.0] [Reference Citation Analysis]
34 Taliyan R, Kakoty V, Sarathlal KC, Kharavtekar SS, Karennanavar CR, Choudhary YK, Singhvi G, Riadi Y, Dubey SK, Kesharwani P. Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease. J Control Release 2022:S0168-3659(22)00058-X. [PMID: 35114208 DOI: 10.1016/j.jconrel.2022.01.044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
35 Nadaf A, Gupta A, Hasan N, Fauziya, Ahmad S, Kesharwani P, Ahmad FJ. Recent update on electrospinning and electrospun nanofibers: current trends and their applications. RSC Adv 2022;12:23808-28. [DOI: 10.1039/d2ra02864f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Gorantla S, Wadhwa G, Jain S, Sankar S, Nuwal K, Mahmood A, Dubey SK, Taliyan R, Kesharwani P, Singhvi G. Recent advances in nanocarriers for nutrient delivery. Drug Deliv Transl Res 2021. [PMID: 34845678 DOI: 10.1007/s13346-021-01097-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]